Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.2800
+0.0100 (3.70%)
Jan 30, 2026, 3:34 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 34.68 million as of January 29, 2026. Its market cap has decreased by -57.69% in one year.
Market Cap
34.68M
Enterprise Value
24.13M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 34.68M, an increase of 82.31%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 34.68M | -8.47% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 81.52M |
| Prescient Therapeutics | 79.92M |
| Amplia Therapeutics | 71.83M |
| Neurizon Therapeutics | 54.75M |
| Entropy Neurodynamics | 51.57M |
| NeuroScientific Biopharmaceuticals | 51.55M |
| Algorae Pharmaceuticals | 35.46M |
| Avecho Biotechnology | 33.06M |